SCHEMBL14818556

SCHEMBL14818556

C=C1c2cc(N(C)C)ccc2CN1c1ccc2c(c1)cc(C)n2C

nearest known ligand 0.32

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ HTR7 P34969 1/20 0.32
▸ HTR6 P50406 1/20 0.32
▸ PABPC1 P11940 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.30
▸ MEN1 O00255 3/20 0.30
▸ KMT2A Q03164 3/20 0.30
▸ KDM4E B2RXH2 2/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13113114 0.86 ALDH1A1 (0.38) HTR1AHTR2AHTR7HTR6PABPC1
SCHEMBL13872273 0.86 METAP1 (0.35) PABPC1ALOX15MAPK1ALDH1A1MEN1
SCHEMBL13872222 0.86 KDM4E (0.31) ALDH1A1KDM4ERAB9AMAPT
SCHEMBL13871869 0.84 HTR2C (0.34) HTR2APABPC1ALOX15MAPK1ALDH1A1
SCHEMBL13871978 0.83 PRKCI (0.38) HTR1AHTR2AHTR7HTR6ALDH1A1
SCHEMBL13871937 0.82 MEN1 (0.36) HTR6PABPC1ALOX15MAPK1ALDH1A1
SCHEMBL13871905 0.82 MEN1 (0.39) PABPC1ALOX15MAPK1ALDH1A1MEN1
SCHEMBL13871950 0.80 MEN1 (0.38) PABPC1ALOX15MAPK1ALDH1A1MEN1
SCHEMBL13872259 0.79 MEN1 (0.39) PABPC1ALOX15MAPK1ALDH1A1MEN1
SCHEMBL13871966 0.78 MEN1 (0.40) HTR2AHTR6PABPC1ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2573080-A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses The United States of America, as Represented by the Secretary, Department of Health and Human Services (US) 2013-03-27 — — EP disclosed
Send feedback